2000 Participants Needed

Surgical Recovery for Bladder Cancer

Recruiting at 10 trial locations
NN
Overseen ByNeema Navai, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather information on patient recovery after radical cystectomy, a surgery to remove the bladder due to cancer. It focuses on collecting both patient-reported outcomes (such as feelings and daily life management) and clinician-reported outcomes (medical observations). The goal is to build a comprehensive Post-Operative Recovery Registry to improve future recovery treatments. This trial suits individuals with bladder cancer undergoing this surgery at MD Anderson Cancer Center or its partner hospitals. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance recovery strategies for future patients.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about the Post-Operative Recovery Registry because it aims to provide detailed insights into how patients recover after radical cystectomy, a major surgery for bladder cancer. Unlike traditional treatments that focus primarily on the immediate surgical outcomes, this registry tracks the long-term recovery process. By analyzing data from various patients, the registry could identify patterns and factors that contribute to better recovery, potentially leading to improved post-operative care and personalized treatment plans. This approach could significantly enhance quality of life for bladder cancer patients by optimizing recovery strategies based on real-world evidence.

Who Is on the Research Team?

NN

Neema Navai, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

1. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo radical cystectomy

1 day

Post-Surgical Recovery

Participants' post-surgical outcomes are assessed using patient-reported and clinician-reported outcomes

3 months

Follow-up

Participants are monitored for safety and effectiveness after surgery

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Post-Operative Recovery Registry
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Bladder Cancer Patients Undergoing Radical CystectomyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity